The potential of circulating microRNA‐125a and microRNA‐125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients

OBJECTIVE: This study was to investigate the changes in circulating microRNA (miR)‐125a and miR‐125b during infliximab (IFX) treatment, and their value in predicting clinical response to IFX in rheumatoid arthritis (RA) patients. METHODS: The plasma samples were obtained from 96 active RA patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Peng, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439431/
https://www.ncbi.nlm.nih.gov/pubmed/32281166
http://dx.doi.org/10.1002/jcla.23329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439431/
https://www.ncbi.nlm.nih.gov/pubmed/32281166
http://dx.doi.org/10.1002/jcla.23329

Ejemplares similares